In this episode of the “CURE® Talks Cancer” podcast Mel Mann discusses his participation in the clinical trial for Gleevec and how it changed the trajectory of his life.

CURE Talks Cancer

94: Gleevec Turned the Clock on a Late-Stage Leukemia Diagnosis

A weekly podcast on what CURE magazine (https://www.curetoday.com) does best: provide Cancer Updates Research and Education. Each week, you'll hear from patients, survivors, caregivers, advocates or health care professionals regarding the entire cancer continuum - ranging from specific cancer types to side effects to the psychological strains a cancer diagnosis can have on an individual and their loved ones. As the largest consumer magazine in the United States for patient, survivors and caregivers, we strive to combine science with humanity to make cancer understandable. To learn more, you can also visit us on Facebook (https://www.facebook.com/curemagazine), Twitter (https://twitter.com/cure_magazine) and Instagram (https://instagram.com/curetoday)!

About

CURE Talks Cancer